Literature DB >> 1563322

Helicobacter pylori and duodenal ulcer. Evidence suggesting causation.

F Mégraud1, H Lamouliatte.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1563322     DOI： 10.1007/bf01296437

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  28 in total

1.  Antibody response to Campylobacter pylori in an ethnic group lacking peptic ulceration.

Authors:  B Dwyer; N X Sun; J Kaldor; W Tee; J Lambert; M Luppino; G Flannery
Journal:  Scand J Infect Dis       Date:  1988

2.  Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients.

Authors:  P Sipponen; K Varis; O Fräki; U M Korri; K Seppälä; M Siurala
Journal:  Scand J Gastroenterol       Date:  1990-10       Impact factor: 2.423

3.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

Review 4.  Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept.

Authors:  C S Goodwin
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

5.  Campylobacter pylori and duodenal ulcers: the gastrin link.

Authors:  S Levi; K Beardshall; G Haddad; R Playford; P Ghosh; J Calam
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

6.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

7.  Intracellular vacuolization caused by the urease of Helicobacter pylori.

Authors:  J K Xu; C S Goodwin; M Cooper; J Robinson
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

8.  Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

Authors:  C S Goodwin; B J Marshall; E D Blincow; D H Wilson; S Blackbourn; M Phillips
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

9.  Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

Authors:  J G Coghlan; D Gilligan; H Humphries; D McKenna; C Dooley; E Sweeney; C Keane; C O'Morain
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

10.  Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication.

Authors:  T J Borody; L L George; S Brandl; P Andrews; E Jankiewicz; N Ostapowicz
Journal:  Am J Gastroenterol       Date:  1992-10       Impact factor: 10.864
View more
  30 in total

1.  Heterogeneity of immunoglobulin G response to Helicobacter pylori measured by the unweighted pair group method with averages.

Authors:  K Mayo; S Pretolani; G Gasbarrini; G Ghironzi; F Megraud
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

2.  Helicobacter species colonizing pig stomach: molecular characterization and determination of prevalence.

Authors:  F Cantet; C Magras; A Marais; M Federighi; F Mégraud
Journal:  Appl Environ Microbiol       Date:  1999-10       Impact factor: 4.792

3.  In vitro activity of rifaximin against Helicobacter pylori.

Authors:  F Mégraud; F Bouffant; C Camou Juncas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

4.  In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.

Authors:  I V Pinchuk; P Bressollier; B Verneuil; B Fenet; I B Sorokulova; F Mégraud; M C Urdaci
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

5.  Helicobacter pylori alters exogenous antigen absorption and processing in a digestive tract epithelial cell line model.

Authors:  T Matysiak-Budnik; K Terpend; S Alain; M J Sanson le Pors; J F Desjeux; F Mégraud; M Heyman
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus.

Authors:  Dulciene Maria Magalhães Queiroz; Andreia Maria Camargos Rocha; Gifone Aguiar Rocha; Sarah Maria Singulano Cinque; Adriana Gonçalves Oliveira; Alicia Godoy; Hugo Tanno
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

7.  Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis.

Authors:  Dulciene Maria Magalhães Queiroz; Gifone Aguiar Rocha; Celso Affonso de Oliveira; Andreia Maria Camargos Rocha; Adriana Santos; Mônica Maria Demas Alvares Cabral; Ana Margarida Miguel Ferreira Nogueira
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type.

Authors:  P Lehours; S Dupouy; B Bergey; A Ruskoné-Foumestraux; J C Delchier; R Rad; F Richy; J Tankovic; F Zerbib; F Mégraud; A Ménard
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

9.  Isolation and preliminary evaluation of a low-molecular-mass antigen preparation for improved detection of Helicobacter pylori immunoglobulin G antibodies.

Authors:  L P Andersen; F Espersen; A Souckova; M Sedlackova; A Soucek
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

10.  Comparison of immunohistochemical and modified Giemsa stains for demonstration of Helicobacter pylori infection in an African population.

Authors:  H R Wabinga
Journal:  Afr Health Sci       Date:  2002-08       Impact factor: 0.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.